Meyer Andrew Hollman

Janux Therapeutics, Inc. · Chief Business Officer

Meyer Andrew Hollman is listed in public filings as officer: Chief Business Officer. This Meyer Andrew Hollman insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Janux Therapeutics, Inc. (JANX). Investors use Meyer Andrew Hollman's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Janux Therapeutics, Inc.JANX$26k1.9k sharesSellJan 2, 2026$13.73--